| 0 |
WRONG ROUTE |
1 |
0.0385 |
| 1 |
THIRD DEGREE CHEMICAL BURN OF SKIN |
1 |
0.0238 |
| 2 |
SECOND DEGREE CHEMICAL BURN OF SKIN |
1 |
0.0167 |
| 3 |
PRODUCT CONTAMINATION CHEMICAL |
3 |
0.0138 |
| 4 |
BURNS THIRD DEGREE |
9 |
0.0085 |
| 5 |
EXPOSURE VIA INHALATION |
1 |
0.0046 |
| 6 |
POST INFLAMMATORY PIGMENTATION CHANGE |
2 |
0.0044 |
| 7 |
PRODUCT EXPIRATION DATE ISSUE |
4 |
0.0029 |
| 8 |
APPLICATION SITE PUSTULES |
1 |
0.0027 |
| 9 |
PRODUCT LOT NUMBER ISSUE |
5 |
0.0023 |
| 10 |
MOLLUSCUM CONTAGIOSUM |
1 |
0.0019 |
| 11 |
CHEMICAL BURN |
2 |
0.0017 |
| 12 |
MONOCLONAL GAMMOPATHY |
1 |
0.0016 |
| 13 |
PRECANCEROUS CONDITION |
1 |
0.0015 |
| 14 |
SKIN CANCER |
32 |
0.0015 |
| 15 |
OTITIS MEDIA ACUTE |
1 |
0.0014 |
| 16 |
APPENDIX CANCER |
1 |
0.0011 |
| 17 |
APPLICATION SITE BURN |
5 |
0.0010 |
| 18 |
SUNBURN |
7 |
0.0009 |
| 19 |
BASAL CELL CARCINOMA |
14 |
0.0009 |
| 20 |
MALIGNANT MELANOMA |
12 |
0.0009 |
| 21 |
BLADDER CANCER STAGE III |
1 |
0.0008 |
| 22 |
APPLICATION SITE HYPERSENSITIVITY |
1 |
0.0008 |
| 23 |
XEROSIS |
1 |
0.0008 |
| 24 |
APPLICATION SITE SCAR |
1 |
0.0008 |
| 25 |
RECALLED PRODUCT ADMINISTERED |
7 |
0.0007 |
| 26 |
HAEMATOLOGICAL MALIGNANCY |
2 |
0.0007 |
| 27 |
PRECANCEROUS SKIN LESION |
1 |
0.0007 |
| 28 |
SQUAMOUS CELL CARCINOMA |
6 |
0.0006 |
| 29 |
APPLICATION SITE SWELLING |
3 |
0.0006 |
| 30 |
TONGUE NEOPLASM MALIGNANT STAGE UNSPECIFIED |
1 |
0.0006 |
| 31 |
MILIARIA |
1 |
0.0006 |
| 32 |
RECALLED PRODUCT |
1 |
0.0006 |
| 33 |
PRODUCT PACKAGE ASSOCIATED INJURY |
1 |
0.0004 |
| 34 |
LIP BLISTER |
1 |
0.0004 |
| 35 |
BLOOD BLISTER |
1 |
0.0003 |
| 36 |
EXPOSURE TO TOXIC AGENT |
1 |
0.0003 |
| 37 |
APPLICATION SITE DRYNESS |
1 |
0.0003 |
| 38 |
APPLICATION SITE RASH |
4 |
0.0003 |
| 39 |
APPLICATION SITE REACTION |
2 |
0.0003 |
| 40 |
PRODUCT CONTAMINATION |
1 |
0.0003 |
| 41 |
APPLICATION SITE EXFOLIATION |
1 |
0.0002 |
| 42 |
MELANOCYTIC NAEVUS |
1 |
0.0002 |
| 43 |
LEUKAEMIA |
2 |
0.0002 |
| 44 |
RASH VESICULAR |
1 |
0.0002 |
| 45 |
NEOPLASM MALIGNANT |
13 |
0.0002 |
| 46 |
URINE ODOUR ABNORMAL |
1 |
0.0002 |
| 47 |
APPLICATION SITE VESICLES |
1 |
0.0002 |
| 48 |
PRODUCT FORMULATION ISSUE |
1 |
0.0002 |
| 49 |
PRODUCT LABEL ISSUE |
1 |
0.0001 |
| 50 |
PAPULE |
1 |
0.0001 |
| 51 |
THERMAL BURN |
1 |
0.0001 |
| 52 |
APPLICATION SITE PAIN |
3 |
0.0001 |
| 53 |
ARTHROPOD BITE |
1 |
0.0001 |
| 54 |
ACUTE MYELOID LEUKAEMIA |
2 |
0.0001 |
| 55 |
FURUNCLE |
1 |
0.0001 |
| 56 |
PHOTOSENSITIVITY REACTION |
2 |
0.0001 |
| 57 |
PRODUCT CONTAINER ISSUE |
1 |
0.0001 |
| 58 |
APPLICATION SITE ERYTHEMA |
3 |
0.0001 |
| 59 |
PRODUCT PACKAGING ISSUE |
1 |
0.0001 |
| 60 |
DERMATITIS CONTACT |
1 |
0.0001 |
| 61 |
VASCULITIS |
1 |
0.0001 |
| 62 |
ABNORMAL WEIGHT GAIN |
1 |
0.0001 |
| 63 |
APPLICATION SITE IRRITATION |
1 |
0.0001 |
| 64 |
DERMATITIS ALLERGIC |
1 |
0.0001 |
| 65 |
RASH PRURITIC |
4 |
0.0001 |
| 66 |
BLISTER |
4 |
0.0001 |
| 67 |
PARAESTHESIA ORAL |
1 |
0.0001 |
| 68 |
HYPOAESTHESIA ORAL |
1 |
0.0001 |
| 69 |
SKIN DISCOLOURATION |
3 |
0.0001 |
| 70 |
EXPIRED PRODUCT ADMINISTERED |
2 |
0.0001 |
| 71 |
SKIN FISSURES |
1 |
0.0001 |
| 72 |
PRODUCT ADMINISTRATION ERROR |
1 |
0.0000 |
| 73 |
DERMATITIS |
1 |
0.0000 |
| 74 |
INCORRECT PRODUCT ADMINISTRATION DURATION |
1 |
0.0000 |
| 75 |
ANGIOEDEMA |
2 |
0.0000 |
| 76 |
RASH PAPULAR |
1 |
0.0000 |
| 77 |
BREAST CANCER |
4 |
0.0000 |
| 78 |
RASH ERYTHEMATOUS |
2 |
0.0000 |
| 79 |
DERMATITIS ATOPIC |
2 |
0.0000 |
| 80 |
SKIN EXFOLIATION |
3 |
0.0000 |
| 81 |
RED BLOOD CELL COUNT DECREASED |
1 |
0.0000 |
| 82 |
LACRIMATION INCREASED |
1 |
0.0000 |
| 83 |
ADVERSE EVENT |
3 |
0.0000 |
| 84 |
EYE DISORDER |
1 |
0.0000 |
| 85 |
URTICARIA |
5 |
0.0000 |
| 86 |
RASH MACULAR |
1 |
0.0000 |
| 87 |
EYE SWELLING |
1 |
0.0000 |
| 88 |
PLASMA CELL MYELOMA |
1 |
0.0000 |
| 89 |
RASH |
11 |
0.0000 |
| 90 |
SKIN IRRITATION |
1 |
0.0000 |
| 91 |
HYPERSENSITIVITY |
4 |
0.0000 |
| 92 |
RENAL CANCER |
1 |
0.0000 |
| 93 |
PRODUCTIVE COUGH |
1 |
0.0000 |
| 94 |
ACCIDENTAL EXPOSURE TO PRODUCT |
2 |
0.0000 |
| 95 |
ECZEMA |
1 |
0.0000 |
| 96 |
BONE PAIN |
1 |
0.0000 |
| 97 |
NASAL CONGESTION |
1 |
0.0000 |
| 98 |
BLADDER CANCER |
1 |
0.0000 |
| 99 |
ILL-DEFINED DISORDER |
1 |
0.0000 |
| 100 |
PRURITUS |
6 |
0.0000 |
| 101 |
SWELLING FACE |
1 |
0.0000 |
| 102 |
PRODUCT QUALITY ISSUE |
2 |
0.0000 |
| 103 |
BURNING SENSATION |
1 |
0.0000 |
| 104 |
SKIN BURNING SENSATION |
1 |
0.0000 |
| 105 |
PROSTATE CANCER |
1 |
0.0000 |
| 106 |
INFLUENZA LIKE ILLNESS |
1 |
0.0000 |
| 107 |
OROPHARYNGEAL PAIN |
1 |
0.0000 |
| 108 |
COUGH |
3 |
0.0000 |
| 109 |
CHEST DISCOMFORT |
1 |
0.0000 |
| 110 |
ERYTHEMA |
2 |
0.0000 |
| 111 |
ABDOMINAL DISTENSION |
1 |
0.0000 |
| 112 |
HAEMORRHAGE |
1 |
0.0000 |
| 113 |
DRY SKIN |
1 |
0.0000 |
| 114 |
CONFUSIONAL STATE |
1 |
0.0000 |
| 115 |
GAIT DISTURBANCE |
1 |
0.0000 |
| 116 |
DRUG INEFFECTIVE |
6 |
0.0000 |
| 117 |
PRODUCT USE IN UNAPPROVED INDICATION |
1 |
0.0000 |
| 118 |
DIZZINESS |
2 |
0.0000 |
| 119 |
ANXIETY |
1 |
0.0000 |
| 120 |
DYSPNOEA |
1 |
0.0000 |
| 121 |
HEADACHE |
1 |
0.0000 |
| 122 |
DEATH |
1 |
0.0000 |